Cargando…

Structural insights into TRPV2 activation by small molecules

Transient receptor potential vanilloid 2 (TRPV2) is involved in many critical physiological and pathophysiological processes, making it a promising drug target. Here we present cryo-electron microscopy (cryo-EM) structures of rat TRPV2 in lipid nanodiscs activated by 2-aminoethoxydiphenyl borate (2-...

Descripción completa

Detalles Bibliográficos
Autores principales: Pumroy, Ruth A., Protopopova, Anna D., Fricke, Tabea C., Lange, Iris U., Haug, Ferdinand M., Nguyen, Phuong T., Gallo, Pamela N., Sousa, Bárbara B., Bernardes, Gonçalo J. L., Yarov-Yarovoy, Vladimir, Leffler, Andreas, Moiseenkova-Bell, Vera Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051106/
https://www.ncbi.nlm.nih.gov/pubmed/35484159
http://dx.doi.org/10.1038/s41467-022-30083-3
_version_ 1784696491468652544
author Pumroy, Ruth A.
Protopopova, Anna D.
Fricke, Tabea C.
Lange, Iris U.
Haug, Ferdinand M.
Nguyen, Phuong T.
Gallo, Pamela N.
Sousa, Bárbara B.
Bernardes, Gonçalo J. L.
Yarov-Yarovoy, Vladimir
Leffler, Andreas
Moiseenkova-Bell, Vera Y.
author_facet Pumroy, Ruth A.
Protopopova, Anna D.
Fricke, Tabea C.
Lange, Iris U.
Haug, Ferdinand M.
Nguyen, Phuong T.
Gallo, Pamela N.
Sousa, Bárbara B.
Bernardes, Gonçalo J. L.
Yarov-Yarovoy, Vladimir
Leffler, Andreas
Moiseenkova-Bell, Vera Y.
author_sort Pumroy, Ruth A.
collection PubMed
description Transient receptor potential vanilloid 2 (TRPV2) is involved in many critical physiological and pathophysiological processes, making it a promising drug target. Here we present cryo-electron microscopy (cryo-EM) structures of rat TRPV2 in lipid nanodiscs activated by 2-aminoethoxydiphenyl borate (2-APB) and propose a TRPV2-specific 2-ABP binding site at the interface of S5 of one monomer and the S4-S5 linker of the adjacent monomer. In silico docking and electrophysiological studies confirm the key role of His521 and Arg539 in 2-APB activation of TRPV2. Additionally, electrophysiological experiments show that the combination of 2-APB and cannabidiol has a synergetic effect on TRPV2 activation, and cryo-EM structures demonstrate that both drugs were able to bind simultaneously. Together, our cryo-EM structures represent multiple functional states of the channel, providing a native picture of TRPV2 activation by small molecules and a structural framework for the development of TRPV2-specific activators.
format Online
Article
Text
id pubmed-9051106
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90511062022-04-30 Structural insights into TRPV2 activation by small molecules Pumroy, Ruth A. Protopopova, Anna D. Fricke, Tabea C. Lange, Iris U. Haug, Ferdinand M. Nguyen, Phuong T. Gallo, Pamela N. Sousa, Bárbara B. Bernardes, Gonçalo J. L. Yarov-Yarovoy, Vladimir Leffler, Andreas Moiseenkova-Bell, Vera Y. Nat Commun Article Transient receptor potential vanilloid 2 (TRPV2) is involved in many critical physiological and pathophysiological processes, making it a promising drug target. Here we present cryo-electron microscopy (cryo-EM) structures of rat TRPV2 in lipid nanodiscs activated by 2-aminoethoxydiphenyl borate (2-APB) and propose a TRPV2-specific 2-ABP binding site at the interface of S5 of one monomer and the S4-S5 linker of the adjacent monomer. In silico docking and electrophysiological studies confirm the key role of His521 and Arg539 in 2-APB activation of TRPV2. Additionally, electrophysiological experiments show that the combination of 2-APB and cannabidiol has a synergetic effect on TRPV2 activation, and cryo-EM structures demonstrate that both drugs were able to bind simultaneously. Together, our cryo-EM structures represent multiple functional states of the channel, providing a native picture of TRPV2 activation by small molecules and a structural framework for the development of TRPV2-specific activators. Nature Publishing Group UK 2022-04-28 /pmc/articles/PMC9051106/ /pubmed/35484159 http://dx.doi.org/10.1038/s41467-022-30083-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Pumroy, Ruth A.
Protopopova, Anna D.
Fricke, Tabea C.
Lange, Iris U.
Haug, Ferdinand M.
Nguyen, Phuong T.
Gallo, Pamela N.
Sousa, Bárbara B.
Bernardes, Gonçalo J. L.
Yarov-Yarovoy, Vladimir
Leffler, Andreas
Moiseenkova-Bell, Vera Y.
Structural insights into TRPV2 activation by small molecules
title Structural insights into TRPV2 activation by small molecules
title_full Structural insights into TRPV2 activation by small molecules
title_fullStr Structural insights into TRPV2 activation by small molecules
title_full_unstemmed Structural insights into TRPV2 activation by small molecules
title_short Structural insights into TRPV2 activation by small molecules
title_sort structural insights into trpv2 activation by small molecules
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051106/
https://www.ncbi.nlm.nih.gov/pubmed/35484159
http://dx.doi.org/10.1038/s41467-022-30083-3
work_keys_str_mv AT pumroyrutha structuralinsightsintotrpv2activationbysmallmolecules
AT protopopovaannad structuralinsightsintotrpv2activationbysmallmolecules
AT fricketabeac structuralinsightsintotrpv2activationbysmallmolecules
AT langeirisu structuralinsightsintotrpv2activationbysmallmolecules
AT haugferdinandm structuralinsightsintotrpv2activationbysmallmolecules
AT nguyenphuongt structuralinsightsintotrpv2activationbysmallmolecules
AT gallopamelan structuralinsightsintotrpv2activationbysmallmolecules
AT sousabarbarab structuralinsightsintotrpv2activationbysmallmolecules
AT bernardesgoncalojl structuralinsightsintotrpv2activationbysmallmolecules
AT yarovyarovoyvladimir structuralinsightsintotrpv2activationbysmallmolecules
AT lefflerandreas structuralinsightsintotrpv2activationbysmallmolecules
AT moiseenkovabellveray structuralinsightsintotrpv2activationbysmallmolecules